Medtronic Price to Book Ratio 2012-2025 | MDT
Historical price to book ratio values for Medtronic (MDT) over the last 10 years. The current price to book ratio for Medtronic as of February 06, 2026 is 2.70.
| Medtronic Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-06 | 102.90 | 2.70 | |
| 2025-10-31 | 90.04 | $38.11 | 2.36 |
| 2025-07-31 | 88.91 | $37.55 | 2.37 |
| 2025-04-30 | 82.82 | $37.64 | 2.20 |
| 2025-01-31 | 88.04 | $38.66 | 2.28 |
| 2024-10-31 | 85.78 | $37.98 | 2.26 |
| 2024-07-31 | 76.59 | $37.55 | 2.04 |
| 2024-04-30 | 75.84 | $38.45 | 1.97 |
| 2024-01-31 | 82.06 | $39.10 | 2.10 |
| 2023-10-31 | 65.59 | $38.83 | 1.69 |
| 2023-07-31 | 80.89 | $38.61 | 2.10 |
| 2023-04-30 | 83.18 | $38.82 | 2.14 |
| 2023-01-31 | 75.89 | $38.80 | 1.96 |
| 2022-10-31 | 78.50 | $39.14 | 2.01 |
| 2022-07-31 | 82.50 | $39.75 | 2.08 |
| 2022-04-30 | 92.34 | $39.62 | 2.33 |
| 2022-01-31 | 91.03 | $39.26 | 2.32 |
| 2021-10-31 | 104.76 | $38.78 | 2.70 |
| 2021-07-31 | 114.21 | $38.42 | 2.97 |
| 2021-04-30 | 113.30 | $38.35 | 2.95 |
| 2021-01-31 | 95.86 | $37.80 | 2.54 |
| 2020-10-31 | 86.17 | $37.39 | 2.30 |
| 2020-07-31 | 82.20 | $37.55 | 2.19 |
| 2020-04-30 | 82.63 | $37.93 | 2.18 |
| 2020-01-31 | 97.10 | $38.75 | 2.51 |
| 2019-10-31 | 91.17 | $37.84 | 2.41 |
| 2019-07-31 | 84.91 | $37.66 | 2.25 |
| 2019-04-30 | 73.57 | $37.45 | 1.96 |
| 2019-01-31 | 72.82 | $37.25 | 1.95 |
| 2018-10-31 | 73.58 | $36.93 | 1.99 |
| 2018-07-31 | 73.55 | $37.23 | 1.98 |
| 2018-04-30 | 64.93 | $37.53 | 1.73 |
| 2018-01-31 | 69.20 | $37.14 | 1.86 |
| 2017-10-31 | 64.51 | $38.10 | 1.69 |
| 2017-07-31 | 66.88 | $37.49 | 1.78 |
| 2017-04-30 | 65.83 | $36.75 | 1.79 |
| 2017-01-31 | 59.91 | $36.16 | 1.66 |
| 2016-10-31 | 64.26 | $36.63 | 1.75 |
| 2016-07-31 | 68.31 | $36.83 | 1.85 |
| 2016-04-30 | 61.40 | $37.21 | 1.65 |
| 2016-01-31 | 58.59 | $36.27 | 1.62 |
| 2015-10-31 | 56.77 | $37.17 | 1.53 |
| 2015-07-31 | 59.87 | $37.36 | 1.60 |
| 2015-04-30 | 56.58 | $37.44 | 1.51 |
| 2015-01-31 | 54.05 | $20.17 | 2.68 |
| 2014-10-31 | 51.38 | $19.75 | 2.60 |
| 2014-07-31 | 46.31 | $19.65 | 2.36 |
| 2014-04-30 | 43.91 | $19.46 | 2.26 |
| 2014-01-31 | 42.03 | $19.34 | 2.17 |
| 2013-10-31 | 42.45 | $18.78 | 2.26 |
| 2013-07-31 | 40.64 | $18.57 | 2.19 |
| 2013-04-30 | 34.15 | $18.38 | 1.86 |
| 2013-01-31 | 33.91 | $17.59 | 1.93 |
| 2012-10-31 | 30.07 | $16.98 | 1.77 |
| 2012-07-31 | 28.34 | $16.91 | 1.68 |
| 2012-04-30 | 27.28 | $16.50 | 1.65 |
| 2012-01-31 | 27.38 | $16.50 | 1.66 |
| 2011-10-31 | 24.50 | $15.86 | 1.54 |
| 2011-07-31 | 25.23 | $15.47 | 1.63 |
| 2011-04-30 | 29.04 | $14.92 | 1.95 |
| 2011-01-31 | 26.50 | $14.36 | 1.85 |
| 2010-10-31 | 24.21 | $13.81 | 1.75 |
| 2010-07-31 | 25.24 | $13.52 | 1.87 |
| 2010-04-30 | 29.64 | $13.33 | 2.22 |
| 2010-01-31 | 28.97 | $13.00 | 2.23 |
| 2009-10-31 | 24.00 | $12.32 | 1.95 |
| 2009-07-31 | 23.68 | $11.88 | 1.99 |
| 2009-04-30 | 21.26 | $11.78 | 1.81 |
| 2009-01-31 | 22.11 | $11.67 | 1.89 |
| 2008-10-31 | 26.46 | $11.29 | 2.34 |
| 2008-07-31 | 34.53 | $10.85 | 3.18 |
| 2008-04-30 | 31.70 | $10.25 | 3.09 |
| 2008-01-31 | 30.20 | $9.76 | 3.09 |
| 2007-10-31 | 30.74 | $10.15 | 3.03 |
| 2007-07-31 | 32.76 | $9.83 | 3.33 |
| 2007-04-30 | 34.14 | $9.60 | 3.56 |
| 2007-01-31 | 34.40 | $9.54 | 3.61 |
| 2006-10-31 | 31.26 | $8.93 | 3.50 |
| 2006-07-31 | 32.37 | $8.61 | 3.76 |
| 2006-04-30 | 32.04 | $8.12 | 3.94 |
| 2006-01-31 | 36.03 | $9.72 | 3.71 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $131.919B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |